![Opinion: Now that Novartis is buying AAA, I'm zeroing in on this potential pharma target - MarketWatch Opinion: Now that Novartis is buying AAA, I'm zeroing in on this potential pharma target - MarketWatch](https://s.marketwatch.com/public/resources/images/MW-FX266_drugph_ZDR_20171030112155.jpg)
Opinion: Now that Novartis is buying AAA, I'm zeroing in on this potential pharma target - MarketWatch
![Novartis Plans $3.9B Acquisition Of Advanced Accelerator Applications - Drug Discovery and Development Novartis Plans $3.9B Acquisition Of Advanced Accelerator Applications - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/Novartis-Logo_Large-1.png)
Novartis Plans $3.9B Acquisition Of Advanced Accelerator Applications - Drug Discovery and Development
![Novartis Completes Tender Offer for Advanced Accelerator Applications - Drug Discovery and Development Novartis Completes Tender Offer for Advanced Accelerator Applications - Drug Discovery and Development](https://drugdiscoverytrends.com/wp-content/uploads/2019/10/shutterstock_518973970.jpg)
Novartis Completes Tender Offer for Advanced Accelerator Applications - Drug Discovery and Development
![Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies | Fierce Pharma Novartis plots 2nd U.S. factory to meet demand for Lutathera and future cancer radiotherapies | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1593609056/Novartis%20headquarters%20Basel.jpg/Novartis%20headquarters%20Basel.jpg?VersionId=c2pF3iLWoI9ZoZcBRRy2fKT9.0Coob44)